Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis in Japan
- 13 October 2009
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 54 (2) , 299-306
Abstract
Background: Post‐transplant outcomes of hemophagocytic lymphohistiocytosis (HLH) patients were analyzed in Japan where Epstein–Barr virus (EBV)‐associated severe forms are problematic.Methods: Fifty‐seven patients (43 familial HLH [12 FHL2, 11 FHL3, 20 undefined], 14 EBV‐HLH) who underwent stem cell transplantation (SCT) between 1995 and 2005 were enrolled based on the nationwide registration.Results: Fifty‐seven patients underwent 61 SCTs, including 4 consecutive SCTs. SCTs were employed using allogeneic donors in 93% of cases (allo 53, twin 1, auto 3). Unrelated donor cord blood transplantation (UCBT) was employed in half of cases (21 FHL, 7 EBV‐HLH). Reduced intensity conditioning was used in 26% of cases. The 10‐year overall survival rates (median ± SE%) were 65.0 ± 7.9% in FHL and 85.7 ± 9.4% in EBV‐HLH patients, respectively. The survival of UCBT recipients was >65% in both FHL and EBV‐HLH patients. Three out of four patients were alive with successful engraftment after second UCBT. FHL patients showed a poorer outcome due to early treatment‐related deaths (P = 0.02). The risk of death for FHL patients having received an unrelated donor bone marrow transplant was marginally higher than that for a related donor SCT (P = 0.05) and that for UCBT (P = 0.07).Conclusions: EBV‐HLH patients had a better prognosis after SCT than FHL patients. FHL patients showed either an equal or better outcome even after UCBT compared with the recent reports. UCB might therefore be acceptable as an alternate SCT source for HLH patients, although the optimal conditioning remains to be determined. Pediatr Blood Cancer 2010;54:299–306.Keywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology of Japan (19591255)
- HLH/LCH Committee in the Japanese Society of Pediatric Hematology
This publication has 41 references indexed in Scilit:
- The Spectrum of Epstein-Barr Virus-Associated Lymphoproliferative Disease in Korea: Incidence of Disease Entities by Age GroupsJournal of Korean Medical Science, 2008
- Nationwide Survey of Hemophagocytic Lymphohistiocytosis in JapanInternational Journal of Hematology, 2007
- SYSTEMIC TYPE EPSTEIN-BARR VIRUS-RELATED LYMPHOPROLIFERATIVE DISEASES IN CHILDREN AND YOUNG ADULTS: Challenges for Pediatric Hemato-Oncologists and Infectious Disease SpecialistsPediatric Hematology and Oncology, 2007
- Familial and acquired hemophagocytic lymphohistiocytosisEuropean Journal of Pediatrics, 2006
- Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-γ-producing lymphocytes and IL-6- and TNF-α-producing macrophagesBlood, 2005
- An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorderBlood, 2004
- Immunological aspects of Epstein–Barr virus infectionCritical Reviews in Oncology/Hematology, 2002
- Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infectionBlood, 2001
- Successful umbilical cord blood transplantation from an unrelated donor for a patient with Epstein–Barr virus-associated hemophagocytic lymphohistiocytosisBone Marrow Transplantation, 2001
- Allogeneic hematopoietic stem cell transplantation for patients with hemophagocytic syndrome (HPS) in JapanBone Marrow Transplantation, 1999